AMES, Iowa, June 7 NewLink Genetics Corporation today announced that Charles Link, M.D., chairman and chief executive officer, will present at the following investor conferences:
Dr. Link will provide an overview of NewLink and its clinical development programs including HyperAcute®-Pancreas Immunotherapy which recently entered Phase 3 testing and presented Phase 2 data at ASCO.
About NewLink Genetics Corporation
NewLink Genetics Corporation is a biopharmaceutical company applying innovative technologies to create new therapeutic agents for patients with cancer and infectious diseases. Its products are designed to enhance the patient's immune system, enabling the body's immune cells to target pathogens and diseased tissues. For more information please visit us at www.newlinkgenetics.com.
-- The 9th Annual Needham Healthcare Conference, Thursday, June 10, at 11:40 a.m. Eastern Time in New York City, NY. The presentation will be webcast live and available for replay at http://www.wsw.com/webcast/needham38/newlink/. -- The Wells Fargo Securities 2010 Healthcare Conference, Wednesday, June 23, at 1:00 p.m. Eastern Time in Boston, MA.
SOURCE NewLink Genetics Corporation